JP2014521089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521089A5 JP2014521089A5 JP2014520229A JP2014520229A JP2014521089A5 JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5 JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5
- Authority
- JP
- Japan
- Prior art keywords
- ndpoi
- antibody
- bead
- complex
- capture antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 16
- 239000011324 bead Substances 0.000 claims 15
- 238000001514 detection method Methods 0.000 claims 10
- 239000012472 biological sample Substances 0.000 claims 8
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 210000002569 neuron Anatomy 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 239000011859 microparticle Substances 0.000 claims 3
- 230000005298 paramagnetic effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161507332P | 2011-07-13 | 2011-07-13 | |
| US61/507,332 | 2011-07-13 | ||
| PCT/US2012/045886 WO2013009667A1 (en) | 2011-07-13 | 2012-07-09 | Method for detection of amyloid beta oligomers in a fluid sample and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521089A JP2014521089A (ja) | 2014-08-25 |
| JP2014521089A5 true JP2014521089A5 (enExample) | 2015-08-27 |
Family
ID=47506433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520229A Pending JP2014521089A (ja) | 2011-07-13 | 2012-07-09 | 液体試料中のアミロイドベータオリゴマーの検出方法およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20130052670A1 (enExample) |
| EP (2) | EP2732286A4 (enExample) |
| JP (1) | JP2014521089A (enExample) |
| KR (1) | KR20140072019A (enExample) |
| CN (1) | CN103782171B (enExample) |
| AU (1) | AU2012282825B2 (enExample) |
| BR (1) | BR112014000671A2 (enExample) |
| CA (1) | CA2840976A1 (enExample) |
| DK (1) | DK2732289T3 (enExample) |
| ES (1) | ES2666840T3 (enExample) |
| MX (1) | MX2014000480A (enExample) |
| RU (1) | RU2014105172A (enExample) |
| WO (2) | WO2013009667A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3449926T3 (da) | 2009-06-17 | 2019-11-11 | Biogen Ma Inc | Sammensætninger og fremgangsmåder til modulering af smn2-splejsning hos et individ |
| US9320793B2 (en) * | 2010-07-14 | 2016-04-26 | Acumen Pharmaceuticals, Inc. | Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| WO2014110291A1 (en) | 2013-01-09 | 2014-07-17 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of smn2 splicing in a subject |
| AU2014352944A1 (en) * | 2013-11-20 | 2016-06-16 | The General Hospital Corporation | Methods and compositions for treating amyloid deposits |
| EP3797780B1 (en) | 2014-04-17 | 2022-09-14 | Biogen MA Inc. | Compositions and methods for modulation of smn2 splicing in a subject |
| WO2015175769A1 (en) | 2014-05-15 | 2015-11-19 | Biogen Ma Inc. | Methods for the detection of amyloid beta oligomers in biological samples |
| US10436802B2 (en) | 2014-09-12 | 2019-10-08 | Biogen Ma Inc. | Methods for treating spinal muscular atrophy |
| MA41480A (fr) * | 2014-10-17 | 2017-12-19 | Glenmark Pharmaceuticals Sa | Anticorps qui se lient au ccr6 et leurs utilisations |
| WO2017033152A1 (en) * | 2015-08-25 | 2017-03-02 | Prothena Biosciences Limited | Methods for detecting phosphorylated alpha-synuclein |
| JP6320651B2 (ja) | 2016-02-08 | 2018-05-09 | シスメックス株式会社 | 被検物質の検出方法および被検物質の検出用試薬キット |
| WO2017218884A1 (en) | 2016-06-16 | 2017-12-21 | Ionis Pharmaceuticals, Inc. | Combinations for the modulation of smn expression |
| JP7299566B2 (ja) * | 2019-07-05 | 2023-06-28 | 株式会社島津製作所 | アミロイドベータに対するモノクローナル抗体、及びその抗体を用いるアミロイドベータ関連ペプチドの測定方法 |
| KR20220148230A (ko) | 2020-02-28 | 2022-11-04 | 아이오니스 파마수티컬즈, 인코포레이티드 | Smn2를 조절하기 위한 화합물 및 방법 |
| KR102798206B1 (ko) * | 2021-06-25 | 2025-04-22 | 장재원 | 동적 형광 또는 x-선의 표준편차와 자기상관을 활용한 조기 진단 시스템 |
| US20240358805A1 (en) * | 2021-08-30 | 2024-10-31 | The Brigham And Women's Hospital, Inc. | Methods and materials to treat neurodegenerative disease |
| WO2024026413A2 (en) * | 2022-07-27 | 2024-02-01 | Durin Technologies, Inc. | Early detection and monitoring of neurodegenerative diseases using a multi-disease diagnostic platform |
| CN117589996A (zh) * | 2022-08-09 | 2024-02-23 | 深圳智源生物医药有限公司 | 强毒性淀粉样蛋白寡聚体的诊断用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665024A (en) | 1984-10-01 | 1987-05-12 | Becton, Dickinson And Company | Fluorescent gram stain |
| US6218506B1 (en) | 1997-02-05 | 2001-04-17 | Northwestern University | Amyloid β protein (globular assembly and uses thereof) |
| US6082205A (en) | 1998-02-06 | 2000-07-04 | Ohio State University | System and device for determining particle characteristics |
| ATE445639T1 (de) | 1999-08-04 | 2009-10-15 | Univ Southern California | Globularer aufbau vom amyloid-beta- protein und deren verwendungen |
| CN1871517A (zh) * | 2002-02-19 | 2006-11-29 | 免疫公司 | 快速有效分离循环癌细胞的方法和试剂 |
| US7807157B2 (en) | 2004-02-20 | 2010-10-05 | Intellect Neurosciences Inc. | Monoclonal antibodies and use thereof |
| AU2005231364A1 (en) * | 2004-04-02 | 2005-10-20 | Merck & Co., Inc. | Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| EP2465872A3 (en) | 2004-10-25 | 2012-12-19 | Merck Sharp & Dohme Corporation | Anti-ADDL antibodies and uses thereof |
| US7731962B2 (en) | 2005-02-14 | 2010-06-08 | Merck & Co., Inc. | Anti-ADDL monoclonal antibody and use thereof |
| RU2008120027A (ru) * | 2005-10-21 | 2009-11-27 | Мерк энд Ко., Инк. (US) | Анти-addl моноклональное антитело и его применение |
| US20090181359A1 (en) * | 2007-10-25 | 2009-07-16 | Lou Sheng C | Method of performing ultra-sensitive immunoassays |
| JP2013511734A (ja) * | 2009-11-24 | 2013-04-04 | プロビオドルグ エージー | アルツハイマー病又は軽度認知障害の診断のための新規診断方法 |
| EP2576617B1 (en) * | 2010-06-04 | 2016-04-27 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | MONOCLONAL ANTIBODIES TARGETING Aß OLIGOMERS |
| ES2573135T3 (es) * | 2010-07-14 | 2016-06-06 | Merck Sharp & Dohme Corp. | Anticuerpo monoclonal anti-ADDL y usos del mismo |
| US9320793B2 (en) * | 2010-07-14 | 2016-04-26 | Acumen Pharmaceuticals, Inc. | Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
-
2012
- 2012-07-09 EP EP12811245.5A patent/EP2732286A4/en not_active Withdrawn
- 2012-07-09 BR BR112014000671A patent/BR112014000671A2/pt not_active IP Right Cessation
- 2012-07-09 KR KR1020147003386A patent/KR20140072019A/ko not_active Withdrawn
- 2012-07-09 AU AU2012282825A patent/AU2012282825B2/en active Active
- 2012-07-09 US US13/544,554 patent/US20130052670A1/en not_active Abandoned
- 2012-07-09 WO PCT/US2012/045886 patent/WO2013009667A1/en not_active Ceased
- 2012-07-09 MX MX2014000480A patent/MX2014000480A/es not_active Application Discontinuation
- 2012-07-09 CN CN201280044598.3A patent/CN103782171B/zh active Active
- 2012-07-09 WO PCT/US2012/045956 patent/WO2013009703A2/en not_active Ceased
- 2012-07-09 CA CA2840976A patent/CA2840976A1/en not_active Abandoned
- 2012-07-09 JP JP2014520229A patent/JP2014521089A/ja active Pending
- 2012-07-09 EP EP12737445.2A patent/EP2732289B1/en active Active
- 2012-07-09 RU RU2014105172/15A patent/RU2014105172A/ru not_active Application Discontinuation
- 2012-07-09 DK DK12737445.2T patent/DK2732289T3/en active
- 2012-07-09 ES ES12737445.2T patent/ES2666840T3/es active Active
-
2013
- 2013-12-20 US US14/137,351 patent/US20140120037A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521089A5 (enExample) | ||
| RU2014105172A (ru) | Способ обнаружения олигомеров бета-амилоида в образце жидкости организма и варианты его применения | |
| JP2010516678A5 (enExample) | ||
| JP2020521951A5 (enExample) | ||
| JP2017184729A5 (enExample) | ||
| JP2017524130A5 (enExample) | ||
| JP2020517919A5 (enExample) | ||
| JP2017505897A5 (enExample) | ||
| JP2013511735A5 (enExample) | ||
| WO2014037588A3 (en) | Methods and compounds for preventing, treating and diagnosing an inflammatory condition | |
| JP2013524774A5 (enExample) | ||
| JP2016118568A5 (enExample) | ||
| KR20160029869A (ko) | 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커 | |
| JP2017522555A5 (enExample) | ||
| JP2014517308A5 (enExample) | ||
| WO2009111254A3 (en) | A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies | |
| Leng et al. | mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes | |
| JP2009515183A5 (enExample) | ||
| WO2015048804A3 (en) | Protein biomarker and uses thereof | |
| JP6420475B2 (ja) | 細気管支炎後の喘息の診断のためのマーカーおよびその用途 | |
| JP2016526167A5 (enExample) | ||
| EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
| Nyawira Maranga et al. | IL‐6 is upregulated in late‐stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense | |
| Steiss et al. | Monitoring of omalizumab therapy by measuring free IgE using a bedside immunoassay | |
| WO2007005627A8 (en) | Tuberculosis antigen detection assays and vaccines |